Overview
Metastatic adenocarcinoma refers to cancer that has spread from its primary site to distant organs, often presenting significant therapeutic challenges due to its systemic nature 1.Diagnosis
Imaging studies (CT, MRI, PET) essential for identifying metastatic sites 1.
Biopsy confirmation of tissue from metastatic sites recommended for definitive diagnosis 1.
Tumor marker assessment may aid in monitoring disease progression but lacks specificity 1.Management
First-line treatments vary by primary tumor type but often include chemotherapy regimens tailored to specific cancer types (e.g., platinum-based for lung cancer) 1.
Targeted therapies and immunotherapy may be adjunctive based on molecular profiling results 1.
Supportive care measures crucial, including symptom management and palliative care integration 1.Special Populations
No specific guidance provided in the abstracts regarding pregnancy, pediatrics, elderly, or comorbidities related to metastatic adenocarcinoma 1.Key Recommendations
Utilize imaging techniques (CT, MRI, PET) for comprehensive staging of metastatic disease (Evidence: Moderate) 1.
Confirm diagnosis through biopsy of metastatic lesions (Evidence: Strong) 1.
Tailor systemic therapy based on primary tumor type and molecular characteristics (Evidence: Moderate) 1.References
1 Negishi K, Kiyama H, Kato S, Teranishi T, Hatakenaka S, Katayama Y et al.. An immunohistochemical study on the river lamprey retina. Brain research 1986. link90470-1)